| Literature DB >> 35496038 |
Nayara Fraccari-Pires1, Hélio José Coelho-Júnior2, Bruno Bavaresco Gambassi3, Ana Paula Cabral de Faria1, Alessandra Mileni Versuti Ritter1, Carolina Souza Gasparetti1, Mariana Rodrigues Pioli1, Olívia Moraes Ruberti3, Silvia Elaine Ferreira-Melo1, Heitor Moreno1, Bruno Rodrigues1,3.
Abstract
Here, we report the acute effects of aerobic (AER), resistance (RES), and combined (COM) exercises on blood pressure, central blood pressure and augmentation index, hemodynamic parameters, and autonomic modulation of resistant (RH) and nonresistant hypertensive (NON-RH) subjects. Twenty participants (10 RH and 10 NON-RH) performed three exercise sessions (i.e., AER, RES, and COM) and a control session. Hemodynamic (Finometer®, Beatscope), office blood pressure (BP), and autonomic variables (accessed through spectral analysis of the pulse-to-pulse BP signal, in the time and frequency domain-Fast Fourrier Transform) were assessed before (T0), one-hour (T1), and twenty-four (T2) hours after each experimental session. There were no changes in office BP, pulse wave behavior, and hemodynamic parameters after (T0 and T1) exercise sessions. However, AER and COM exercises significantly reduced sympathetic modulation in RH patients. It is worth mentioning that more significant changes in sympathetic modulation were observed after AER as compared to COM exercise. These findings suggest that office blood pressure, arterial stiffness, and hemodynamic parameters returned to baseline levels in the first hour and remained stable in the 24 hours after the all-exercise sessions. Notably, our findings bring new light to the effects of exercise on RH, indicating that RH patients show different autonomic responses to exercise compared to NON-RH patients. This trial is registered with trial registration number NCT02987452.Entities:
Mesh:
Year: 2022 PMID: 35496038 PMCID: PMC9046001 DOI: 10.1155/2022/8202610
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
General characteristics of resistant hypertensive subjects (RH) and nonresistant hypertensive subjects (NON-RH).
| RH ( | NON-RH ( |
| |
|---|---|---|---|
|
| |||
| Age (years) | 60 ± 9 | 54 ± 13 | 0.66 |
| Female gender, | 6 (60) | 5 (50) | 1 |
| Diabetes mellitus, | 10 (100) | 5 (50) | 0.03 |
| BMI (kg/m2) | 31 ± 5 | 32 ± 7 | 0.18 |
| Free-fat mass (kg) | 54 ± 18.5 | 61 ± 10.6 | 0.40 |
| Fat mass (kg) | 25 ± 10 | 26 ± 14 | 0.32 |
| Total body water (L) | 75 ± 2 | 75 ± 3 | 0.17 |
| Basal metabolic rate (cals/day) | 1765 ± 482 | 1996 ± 540 | 0.39 |
| Office SBP (mmHg) | 147 ± 11 | 134 ± 8 | 0.02 |
| Office DBP (mmHg) | 85 ± 7 | 78 ± 6 | 0.08 |
| Office MBP (mmHg) | 56 ± 22 | 49 ± 10 | 0.12 |
| Office HR (bpm) | 59 ± 6 | 70 ± 9 | 0.03 |
|
| |||
| HbA1C (%) | 7 ± 2 | 6 ± 0.7 | 0.13 |
| Glucose (mg/mL) | 97 ± 25 | 98 ± 20 | 0.07 |
| Creatinine (mg/mL) | 0.8 ± 0.2 | 0.8 ± 0.2 | 0.81 |
| Aldosterone (pg/mL) | 100 ± 141 | 132 ± 95 | 0.64 |
| Creat Clear (mL/min/1.73m2) | 83 ± 66 | 89 ± 65 | 0.86 |
| Cholesterol (mg/mL) | 188 ± 48 | 175 ± 40 | 0.55 |
| HDL-c (mg/mL) | 44 ± 9 | 38 ± 7 | 0.07 |
| LDL-c (mg/mL) | 109 ± 35 | 106 ± 46 | 0.88 |
| Triglycerides (mg/mL) | 125 ± 75 | 143 ± 108 | 0.97 |
|
| |||
| Number of classes | 4 ± 1 | 2 ± 1 | 0.13 |
| Diuretics, | 10 (100) | 5 (50) | 0.03 |
| Spironolactone, | 2 (20) | 2 (20) | 1 |
| Beta-blockers, | 8 (80) | 6 (60) | 0.63 |
| ACEIs and ARBs, | 5 (50) | 7 (70) | 0.65 |
| CCBs, | 8 (80) | 3 (30) | 0.07 |
| Others, | 0 | 0 | 1 |
According to data distribution, values are expressed as mean ± standard deviation or median (1st, 3rd quartiles). RH: resistant hypertensive subjects; NON-RH: nonresistant hypertensive subjects; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; MBP: mean blood pressure; HR: heart rate; HbA1C: glycated hemoglobin; Creat Clear: creatinine clearance; LDL and HDL: low- and high-density lipoproteins, respectively; antiHT: antihypertensive drugs; ACEIs: angiotensin-converting enzyme inhibitors; ARBS: angiotensin receptor blockers; CCBs: calcium channel blockers.
Figure 1Effects of exercise sessions on office blood pressure in RH (a–d) and NON-RH (e–h) at baseline (T0), postexercise (T1), and 24 hs (T2) after exercise sessions. AER: Aerobic; RES: resistance; COM: combined; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; HR: heart rate.
Figure 2Effects of exercise sessions on central blood pressure and augmentation index in RH (a–d) and NON-RH (e–h) at baseline (T0) and postexercise (T1). AER: aerobic; RES: resistance; COM: combined; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; AIx: augmentation index.
Figure 3Effects of exercise sessions on hemodynamic parameters in RH (a–g) and NON-RH (h–n) at baseline (T0), postexercise (T1), and 24 hs (T2) after exercise sessions. AER: aerobic; RES: resistance; COM: combined; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; SV: stroke volume; CO: cardiac output; HR: heart rate; TRP: total peripheral vascular resistance.
Effect size for hemodynamic parameters after the experimental sessions in RH.
| AER | RES | COM | ||
|---|---|---|---|---|
|
| ||||
| SBP | T1 | 0.87 (large) | 0.31 (small) | 0.27 (small) |
| T2 | 0.33 (small) | -0.03 | 0.57 (medium) | |
| DBP | T1 | 0.51 (medium) | 0.65 (medium) | 0.25 (small) |
| T2 | 0.32 (small) | -0.17 | 0.78 (medium) | |
| MAP | T1 | 0.80 (large) | 0.35 (small) | 0.46 (small) |
| T2 | 0.40 (small) | -0.09 | 0.80 (large) | |
| SV | T1 | 0.06 | 0.11 | 0.69 (medium) |
| T2 | -0.16 | 0.20 (small) | 0.22 (small) | |
| CO | T1 | 0.33 (small) | 0 | 0.5 (medium) |
| T2 | 0 | 0.39 (small) | 0.5 (medium) | |
| HR | T1 | -0.63 (medium) | -0.62 (medium) | -0.66 (medium) |
| T2 | 0 | |||
| TPR | T1 | 0.11 | 0.55 (medium) | 0.52 (medium) |
| T2 | -0.25 (small) | -0.51 (medium) | 0.62 (medium) | |
| Office | ||||
| SBP | T1 | 0.51 (medium) | 0.40 (small) | 0.35 (small) |
| T2 | 0.66 (medium) | 0.43 (small) | 0.77 (medium) | |
| DBP | T1 | 0.65 (medium) | 0.43 (small) | 0.47 (small) |
| 24 | 0.63 (medium) | 0.69 (medium) | 0.78 (medium) | |
| PP | T1 | 0.32 (small) | 0.34 (small) | 0.11 |
| T2 | 0.47 (small) | 0.17 | 0.56 (medium) | |
| HR | T1 | -0.76 (medium) | -0.75 (medium) | -0.91 (large) |
| T2 | -1.17 (large) | -1.53 (large) | -1.11 (large) | |
|
| ||||
| Central SBP | T1 | 0.84 (large) | 0.59 (medium) | 0.59 (medium) |
| Central DBP | T1 | 0.65 (medium) | 0.31 (small) | 0.49 (small) |
| Central PP | T1 | 0.78 (medium) | 0.60 (medium) | 0.52 (medium) |
| AIx | T1 | 0.89 (large) | 0.72 (medium) | 0.81 (large) |
AER: aerobic; RES: resistance; COM: combined; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; PP: pulse pressure; SV: stroke volume; CO: cardiac output; HR: heart rate; TPR: total peripheral vascular resistance; AIx: augmentation index; T1: postexercise; T2 : 24 hours after exercise protocols.
Effect size for hemodynamic parameters after the experimental sessions in NON-RH.
| AER | RES | COM | ||
|---|---|---|---|---|
|
| ||||
| SBP | T1 | 0.28 (small) | -0.44 (small) | -0.29 (small) |
| T2 | -0.29 (small) | 0.27 (small) | -0.46 (small) | |
| DBP | T1 | 0.20 (small) | -0.09 | -0.34 (small) |
| T2 | -0.17 | 0 | -0.59 (medium) | |
| MAP | T1 | 0.26 (small) | 0.07 | -0.32 (small) |
| T2 | -0.23 (small) | 0.23 (small) | -0.37 (small) | |
| SV | T1 | 0.20 (small) | 0.35 (small) | 0.33 (small) |
| T2 | -0.11 | 0.24 (small) | 0.27 (small) | |
| CO | T1 | 0 | 0 | -0.5 (medium) |
| T2 | -0.19 | 0.5 (medium) | -0.5 (medium) | |
| HR | T1 | -0.82 (large) | -0.16 | -0.47 (small) |
| T2 | 0.09 | 0 | 0.17 | |
| TPR | T1 | -0.00 | 0.61 (medium) | -0.32 (small) |
| T2 | -0.46 (small) | 0.58 (medium) | -0.74 (medium) | |
| Office | ||||
| SBP | T1 | 0.46 (small) | -0.12 | 0.24 (small) |
| T2 | 0.97 (large) | 0.31 (small) | 0.85 (large) | |
| DBP | T1 | 0.09 | 0 | -0.09 |
| T2 | 0.65 (medium) | 0.60 (medium) | 0.34 (small) | |
| PP | T1 | 0.32 (small) | -0.15 | 0.41 (small) |
| T2 | 0.50 (medium) | 0.05 | 0.82 (large) | |
| HR | T1 | 0 | 0.08 | -0.30 (small) |
| T2 | -0.60 (medium) | -0.77 (medium) | -0.47 (small) | |
|
| ||||
| Central SBP | T1 | 0.35 (small) | -0.13 | 0.13 |
| Central DBP | T1 | 0.25 (small) | 0 | -0.09 |
| Central PP | T1 | 0.18 | -0.17 | 0.35 (small) |
| AIx | T1 | 0 | 0 | 0 |
AER: aerobic; RES: resistance; COM: combined; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; PP: pulse pressure; SV: stroke volume; CO: cardiac output; HR: heart rate; TPR: total peripheral vascular resistance; AIx: augmentation index; T1: postexercise; T2 : 24 hours after exercise protocols.
Pulse interval and systolic blood pressure variability parameters of RH at baseline (T0), postexercise (T1), and 24 hs (T2) after exercise sessions.
| Var-IP (ms2) | RMSSD (ms) | LF (ms2) | LF (%) | HF (ms2) | HF (%) | LF/HF | Var-SBP (mmHg2) | LF (mmHg2) | AI, LF, (ms/mmHg) | |
|---|---|---|---|---|---|---|---|---|---|---|
| AER | ||||||||||
| T0 | 2339 ± 1734 | 47 ± 32 | 751 ± 440 | 58 ± 19 | 898 ± 1258 | 41 ± 19 | 1.9 ± 1.2 | 73 ± 40 | 27 ± 8 | 5 ± 1 |
| T1 | 982 ± 592a | 25 ± 16 | 488 ± 434 | 59 ± 30 | 280 ± 360 | 40 ± 30 | 3.8 ± 3.6 | 75 ± 46 | 45 ± 34 | 3 ± 1 |
| T2 | 2034 ± 1320 | 65 ± 42 | 367 ± 388a | 32 ± 17a | 715 ± 602a | 67 ± 17 | 0.5 ± 0.4 | 62 ± 13 | 11 ± 9 | 6 ± 3 |
| RES | ||||||||||
| T0 | 2269 ± 1750 | 59 ± 60 | 464 ± 393 | 45 ± 21 | 651 ± 604 | 54 ± 21 | 1.2 ± 1.3 | 83 ± 54 | 9 ± 6 | 8 ± 4 |
| T1 | 1991 ± 2656 | 33 ± 18 | 833 ± 1549 | 58 ± 21 | 422 ± 546 | 41 ± 21 | 1.8 ± 1.2 | 89 ± 53 | 9 ± 7 | 6 ± 3 |
| T2 | 2880 ± 2381 | 52 ± 34 | 546 ± 424 | 43 ± 21 | 882 ± 1035 | 56 ± 21 | 1.1 ± 1.0 | 69 ± 22 | 12 ± 9 | 6 ± 3 |
| COM | ||||||||||
| T0 | 3342 ± 1535 | 56 ± 28 | 961 ± 789 | 44 ± 17 | 1393 ± 985 | 55 ± 17 | 0.9 ± 0.5 | 75 ± 27 | 16 ± 4 | 7 ± 3 |
| T1 | 1513 ± 939a | 31 ± 17a | 446 ± 600 | 45 ± 25 | 620 ± 966 | 54 ± 25 | 1.5 ± 1.8 | 79 ± 21 | 19 ± 5 | 7 ± 13 |
| T2 | 3843 ± 2459b | 43 ± 22 | 838 ± 692 | 47 ± 15 | 905 ± 844 | 52 ± 15 | 1.0 ± 0.5 | 87 ± 19 | 12 ± 7 | 10 ± 9 |
AER: aerobic; RES: resistance; COM: combined; Var-IP: variance of pulse interval; RMSSD: root mean square of the successive differences; LF: low-frequency band; HF: high-frequency band; Var-SBP: variance of systolic blood pressure; AI: alpha index; T0: baseline; T1: immediately after; T2: 24 hs after. aP < 0.05 vs. T0; bP < 0.05 vs. AER.
Pulse interval and systolic blood pressure variability parameters of NON-RH at baseline (T0), postexercise (T1), and 24 hs (T2) after exercise sessions.
| Var-IP (ms2) | RMSSD (ms) | LF (ms2) | LF (%) | HF (ms2) | HF (%) | LF/HF | Var-SBP (mmHg2) | LF (mmHg2) | AI, LF, (ms/mmHg) | |
|---|---|---|---|---|---|---|---|---|---|---|
| AER | ||||||||||
| T0 | 3919 ± 2705 | 47 ± 22 | 608 ± 526 | 43 ± 14 | 911 ± 833 | 56 ± 14 | 0.9 ± 0.7 | 50 ± 23 | 22 ± 12 | 5 ± 1 |
| T1 | 2227 ± 2038 | 22 ± 9a | 812 ± 1459 | 55 ± 15 | 741 ± 1358 | 44 ± 15 | 1.6 ± 1.2 | 44 ± 19 | 24 ± 10 | 3 ± 2 |
| T2 | 2639 ± 1793 | 34 ± 14 | 436 ± 376 | 44 ± 17 | 649 ± 519 | 55 ± 17 | 1.0 ± 0.8 | 35 ± 20 | 18 ± 10 | 4 ± 1 |
| RES | ||||||||||
| T0 | 2786 ± 2183 | 34 ± 15 | 438 ± 374 | 52 ± 16 | 434 ± 436 | 47 ± 16 | 1.4 ± 1.2 | 56 ± 27 | 29 ± 17 | 3 ± 1 |
| T1 | 1963 ± 1484 | 28 ± 12 | 361 ± 288 | 52 ± 14 | 370 ± 341 | 47 ± 14 | 1.4 ± 1.1 | 47 ± 23 | 25 ± 11 | 4 ± 2 |
| T2 | 2261 ± 1702 | 31 ± 15 | 329 ± 282 | 50 ± 17 | 477 ± 482 | 49 ± 17 | 1.2 ± 1.1 | 40 ± 21 | 20 ± 9 | 4 ± 2 |
| COM | ||||||||||
| T0 | 2776 ± 1416 | 45 ± 18 | 740 ± 564 | 57 ± 12 | 496 ± 392b | 42 ± 12 | 1.2 ± 0.4 | 67 ± 34 | 12 ± 8 | 7 ± 4 |
| T1 | 1561 ± 1105 | 35 ± 25 | 301 ± 271 | 55 ± 17 | 294 ± 300 | 44 ± 17 | 1.6 ± 1.4 | 58 ± 33 | 12 ± 9 | 5 ± 3 |
| T2 | 2696 ± 1716 | 36 ± 11 | 506 ± 429 | 53 ± 14 | 489 ± 435 | 46 ± 14 | 1.6 ± 1.5 | 80 ± 69 | 12 ± 10 | 6 ± 3 |
AER: aerobic; RES: resistance; COM: combined; Var-IP: variance of pulse interval; RMSSD: root mean square of the successive differences; LF: low-frequency band; HF: high-frequency band; Var-SBP: variance of systolic blood pressure; AI: alpha index; T0: baseline; T1: immediately after; T2: 24 hs after. aP < 0.05 vs. T0; bP < 0.05 vs. AER.